Acute Research

R&D-driven API & formulation partner. EU-GMP capable manufacturing • Sterile injectable expertise • Contract R&D & pilot scale services.

Three divisions: API Division • Formulation Division • R&D & Contract Services

API Division

R&D-led process development and EU-GMP capable manufacturing with strong QA, regulatory support (DMF/CTD) and plant support for niche and sterile-use APIs.

Facility: Newly built, segregation-friendly suites with strict internal specs for sterile injectable APIs.

Key Products: Tigecycline, Nifedipine, Baclofen, Torasemide, Blonanserin, Naftifine HCl, Noradrenaline, Adrenaline, Dexmedetomidine

Explore API products →

Formulation Division

Focused portfolio of sterile injectables and topical formulations — lyophilization expertise for stable parenteral presentations and topical wound-care solutions.

Products: Tigecycline 50mg lyophilized injection, Naftifine HCl 1% & 2% topical, Feracrylum 1% & 3% gel and sterile solution for wound care.

Explore formulations →

R&D & Contract Services

State-of-the-art analytical and process R&D labs. Flexible FTF / FFS / lab-on-rent models with pilot scale and method validation services.

Equipment: 16 fume hoods, HPLC systems (Agilent, Shimadzu), pilot lyophilizer, analytical balances, method development capabilities.

Book a facility tour →

Acute Chemtech

Acute Chemtech is our manufacturing & scale-up vertical. For commercial-scale operations and purchase enquiries please contact the team.

Learn more about Acute Chemtech →

About Acute Research

We are an R&D-driven company with a strong QA culture. We specialise in niche, high-value APIs with full regulatory and plant support for customers who demand stringent specs and sterile-use readiness.

Our EU-GMP capable facility features dedicated suites for sterile-use APIs, validated processes, robust stability programs and full documentation packages (DMF / CTD / batch records) for regulated markets.

EU-GMP

Capable Suites

Sterile

Injectable Expertise

DMF/CTD

Documentation

Our mission and strengths

Acute Research Centre (ARC) focuses on novel chemistry and cost-effective technologies to provide early entry opportunities in regulated and emerging markets. We develop APIs and intermediates free from genotoxic impurities, benchmarked to innovator quality.

Our integrated teams bring together chemistry, process engineering, analytical sciences and regulatory affairs. With more than 35 years of experience, patents and publications worldwide, ARC supports the full pathway from route scouting to commercial manufacturing and global submissions.

Our divisions

Development Process

1

Route Identification

Novel chemistry and process development for APIs and intermediates

2

Scale-up & Optimization

Process optimization and scale-up from milligram to kilogram

3

Analytical Development

Method development, validation and quality control

4

Regulatory Support

GMP compliance and global regulatory submissions

Ready to Partner with ARC?

Need support with API development, CRAMS, or regulatory dossier preparation? Our team is ready to help you achieve your development goals.

Get In Touch